Combined cytogenetic testing and fluorescence in situ hybridization analysis in the study of chronic lymphocytic leukemia and multiple myeloma

Cancer Genetics and Cytogenetics

Volumn 153, Issue 1, 2004, Pages 73-76

  Wiktor, Anne ^a   Van Dyke, Daniel L ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CENTROMERE; CHROMOSOME 11Q; CHROMOSOME 12; CHROMOSOME 13Q; CHROMOSOME 17P; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHRONIC LYMPHATIC LEUKEMIA; CYTOGENETICS; DNA PROBE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; KARYOTYPING; MAJOR CLINICAL STUDY; METAPHASE; MULTIPLE MYELOMA; PRIORITY JOURNAL; AGED; ANEUPLOIDY; BLOOD; BONE MARROW; FEMALE; GENETICS; MALE; MIDDLE AGED; PATHOLOGY;

AGED; ANEUPLOIDY; BONE MARROW; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MALE; MIDDLE AGED; MULTIPLE MYELOMA;

EID: 4644345266     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2004.03.006     Document Type: Article

References (12)

1. Kay N.E., Jelinek D.F. B-cell: is the enigma of disease heterogeneity about to be revealed? Blood. 15:2002;1110-1111
2. Debes-Marun C.S., Dewald G.W., Bryant S., Picken E., Santana-Davila R., Gonzalez-Paz N., Winkler J.M., Kyle R.A., Gertz M.A., Witzig T.E., Dispenzieri A., Lacy M.Q., Rajkumar S.V., Lust J.A., Greipp P.R., Fonseca R. Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma. Leukemia. 17:2003;427-436
3. Wiktor A., Rybicki B.A., Piao Z.S., Shurafa M., Barthel B., Maeda K., Van Dyke D.L. Clinical significance of Y chromosome loss in hematologic disease. Genes Chromosomes Cancer. 27:2000;11-16
4. Mossafa H, Huret JL. Chronic lymphocytic leukaemia (CLL). Atlas Genet Cytogenet Oncol Haematol, available at http://www.infobio gen.fr/services/ chromcancer/Anomalies/CLL.html. Accessed August 1997.
5. Dohner H., Stilgenbauer S., Bener A., Leupolt E., Krober A., Bullinger L., Dohner K., Bentz M., Lichter P. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med. 343:2000;1910-1916
6. Dewald G.W., Brockman S.R., Paternoster S.F., Bone N.D., O'Fallon J.R., Allmer C., James C.J., Jelinke D.F., Tschumper R.C., Hanson C.A., Pruthi R.K., Witzig T.E., Call T.G. Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cll chronic lymphocytic leaukemia. Br J Haematol. 121:2003;287-295
7. Crossen P.E. Genes and chromosomes in chronic B-cell leukemia. Cancer Genet Cytogenet. 94:1997;44-51
8. Cuneo A. Classification of B-cell chronic lymproliferative disorders (CLD: cytogenetic entities, immunophenotype and clinical features). Atlas Genet Cytogenet Oncol Haematol, available at http://www. infobiogen.fr/services/ chromcancer/Deep/BCLDcalssifID20013.html. Accessed February 2000.
9. Konigsberg R., Zojer N., Ackerman J., Kromer E., Kittler H., Fritz E., Kaufman H., Nosslinger T., Riedl L., Gisslinger H., Jager U., Simonitsch I., Heinz R., Ludwig H., Huber H., Drach J. Predictive role of interphase cytogenetics for survival of patients with multiple myeloma. J Clin Oncol. 4:2000;804-812
10. Harrison C.J., Mazzullo H., Cheung K.L., Gerrard G., Jalali G.R., Mehta A., Osier D.G., Orchard K.H. Cytogenetics of multiple myeloma: interpretation of fluorescence in situ hybridization results. Br J Haematol. 120:2003;944-952
11. Seong C., Delasalle K., Hayes K., Weber D., Dimoploulos M., Swantkowski J., Huh Y., Glassman A., Champlin R., Alexanian R. Prognostic value of cytogenetics in multiple myeloma. Br J Haematol. 101:1998;189-194
12. Fonseca R., Blood E., Rue M., Harrington D., Oken M.M., Kyle R.A., Dewald G.W., Van Ness B., Van Wier S.A., Henderson K.J., Bailey R.J., Greipp P.R. Clinical and biological implications of recurrent genomic aberrations in myeloma. Blood. 101:2003;4569-4575